RxDoctor Payments Data

Atlanta Cranias, PA

Physician Assistant · Orange City, FLNPI 1720656531

Payments from drug & device makers

$13,511in general payments, 2019–2025

Across 547 payments — averaging $24.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$4K
  • Merck$732
  • Johnson & Johnson$552
  • Seagen Inc.$543
  • Eisai Inc.$515
  • Daiichi Sankyo Inc.$503
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$10,12375%
  • Education$7075%
  • Other$2,68120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis91$3,759
Merck36$732
Johnson & Johnson32$552
Seagen Inc.16$543
Eisai Inc.25$515
Daiichi Sankyo Inc.26$503
AstraZeneca(2 entities)19$482
Pfizer24$480
Bristol Myers Squibb19$425
Lilly USA, LLC14$383
AbbVie13$352
Astellas Pharma US Inc12$330
Incyte Corporation14$328
Amgen21$290
Gilead9$222
Array Biopharma Inc13$220
Pharmacyclics LLC, An Abbvie Company8$217
Sobi, Inc9$213
Pharmacosmos Therapeutics Inc.8$199
Beigene USA, Inc.10$182
Takeda Pharmaceuticals U.S.A., Inc.7$173
Regeneron Healthcare Solutions, Inc.7$162
Tersera Therapeutics LLC8$157
E.r. Squibb & Sons, L.L.C.9$155
Bayer7$141
EMD Serono, Inc.6$132
Jazz Pharmaceuticals Inc.6$129
GSK5$124
Sanofi6$113
Genentech USA, Inc.7$106
Dendreon Pharmaceuticals LLC4$101
Beone Medicines USA, Inc.4$93
Taiho Oncology, Inc.4$77
Agios Pharmaceuticals, Inc.4$77
Mirati Therapeutics, Inc.4$73
Servier Pharmaceuticals LLC3$64
Genmab U.S., Inc.2$54
Ipsen Biopharmaceuticals, Inc3$51
Stemline Therapeutics Inc.2$48
Novocure Inc.2$48
G1 Therapeutics, Inc.3$46
Pharmaessentia USA Corporation2$43
Puma Biotechnology, Inc.3$41
Geron Corporation2$40
Iovance Biotherapeutics, Inc.2$33
Legend Biotech USA Inc.1$24
CTI Biopharma Corp.1$24
Karyopharm Therapeutics Inc.1$23
AVEO Pharmaceuticals, Inc.1$21
Acrotech Biopharma Inc.1$21
Deciphera Pharmaceuticals Inc.1$21
Syndax Pharmaceuticals, Inc.1$20
Morphosys, US Inc.1$18
Exelixis Inc.1$18
Alnylam Pharmaceuticals Inc.1$18
Springworks Therapeutics, Inc.1$17
GT Medical Technologies, Inc1$17
Fennec Pharmaceuticals, Inc.1$16
Kyowa Kirin, Inc.1$16
Mayne Pharma Commercial LLC1$14

How this compares

$13,511 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$62,805
Medicare patients
55
Services billed
4,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban51$59,183
XareltoRivaroxaban20$19,521
Vitamin D2Ergocalciferol (Vitamin D2)133$1,122
Letrozole22$585
Anastrozole13$242

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$480$59,18351 claims
Johnson & JohnsonXarelto$552$19,52120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,062 physician assistant providers in Florida.

Other physician assistant in Orange City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →